Theratechnologies to Host Conference Call

(firmenpresse) - MONTREAL, QUEBEC -- (Marketwire) -- 10/29/12 -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THER) (Theratechnologies) announced today that it will host a conference call to provide an update of its business plan on Tuesday, October 30, 2012 at 8:45 a.m. (ET). The call will be hosted by Luc Tanguay, President and Chief Executive Officer. The conference call will be open to questions from financial analysts. Media and other interested individuals are invited to participate on a "listen-only" basis.

The conference call can be accessed by dialing 1-800-743-9807 (North America) or 1-416-981-9000 (International). The conference call will also be accessible via webcast at . Audio replay of the conference call will be available until November 13, 2012, by dialing 1-800-558-5253 (North America) or 1-416-626-4100 (International) and by entering the playback code 21609750.



Contacts:
Roch Landriault
514-843-2345

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 29.10.2012 - 11:30 Uhr
Sprache: Deutsch
News-ID 197043
Anzahl Zeichen: 0

contact information:
Town:

MONTREAL, QUEBEC

Kategorie:

Biotech

Diese Pressemitteilung wurde bisher 210 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Theratechnologies to Host Conference Call"
steht unter der journalistisch-redaktionellen Verantwortung von

Theratechnologies Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Theratechnologies Announces Decision by the FDA to Extend the Ibalizumab Review ...

MONTREAL, QUEBEC -- (Marketwired) -- 11/13/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) announced that it was notified today by its partner, TaiMed Biologics, Inc. ("TaiMed"), that the U.S. Food and Drug Administration (&quo ...

Theratechnologies Announces Financial Results for Third Quarter of 2017 ...

MONTREAL, QUEBEC -- (Marketwired) -- 10/05/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the third quarter ended August 31, 2017.Third quarter 2017 financial highlights"With three quarters ...

Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab P ...

MONTREAL, QUEBEC -- (Marketwired) -- 10/04/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced 48-week efficacy and safety results for ibalizumab in patients infected with multidrug resistant HIV-1 who completed the 24-week P ...

Alle Meldungen von Theratechnologies Inc.